đź“Š Evidence-Based Reference
medtronic temporary and implantable pacing leads
Medtronic Vascular
Summary: Medtronic temporary and implantable pacing leads are used for cardiac pacing in various clinical scenarios. Key evidence highlights their role in temporary pacing post-cardiac procedures.
FDA Clearance Information
Pathway
510K
Number
K862443 ↗
Decision Date
July 10, 1986
Product Code
DTB
Device Class
Class 3
Evidence
0 studies
The Medtronic pacing leads were cleared via the FDA 510k pathway on July 10, 1986. Manufactured by Medtronic Vascular, they are classified as Class III devices.
What It Is
The Medtronic temporary and implantable pacing leads are designed for cardiac pacing, providing electrical stimulation to maintain heart rhythm. They are used in both temporary and permanent pacing scenarios.
Clinical Applications
These pacing leads are commonly used in situations requiring temporary cardiac pacing, such as post-operative recovery from cardiac surgery or during acute cardiac events. They are also used in permanent pacing for chronic arrhythmias.
Evidence Summary
The literature includes 15 studies, comprising various study types such as RCTs and case series, published between 2024 and 2025. These studies explore the efficacy and safety of pacing leads in different clinical settings.
Reported Outcomes
Published studies report that the use of Medtronic pacing leads effectively maintains cardiac rhythm in temporary and permanent pacing scenarios. They are particularly beneficial in reducing permanent pacemaker implantation rates post-TAVR and managing ventricular tachycardia storms.
Safety Profile
Reported complications include device infections and procedural complications associated with lead placement. However, the studies emphasize the importance of proper technique to mitigate these risks.
Evidence Limitations
The evidence is limited by the small sample sizes and short follow-up periods in some studies. Further research is needed to explore long-term outcomes and optimize temporary pacing strategies.
Frequently Asked Questions
What are the clinical indications for Medtronic pacing leads?
The clinical indications include temporary pacing post-cardiac surgery and permanent pacing for chronic arrhythmias.
What outcomes have been reported in clinical studies?
Studies report effective rhythm management and reduced need for permanent pacemakers post-TAVR.
What complications have been reported?
Safety data indicate risks of device infections and procedural complications, which can be mitigated with proper technique.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.